• Bang S, Yoo S, Yang TJ, Cho H, Kim YG, Hwang SW (2010). Resolvin D1 attenuates activation of sensory transient receptor potential channels leading to multiple anti-nociception. Br J Pharmacol 161: 707720.
  • Cheng JK, Ji RR (2008). Intracellular signaling in primary sensory neurons and persistent pain. Neurochem Res 33: 19701978.
  • Gilroy DW, Colville-Nash PR, Willis D, Chivers J, Paul-Clark MJ, Willoughby DA (1999). Inducible cyclooxygenase may have anti-inflammatory properties. Nat Med 5: 698701.
  • Hess A, Axmann R, Rech J, Finzel S, Heindl C, Kreitz S et al. (2011). Blockade of TNF- rapidly inhibits pain responses in the central nervous system. Proc Natl Acad Sci U S A 108: 37313736.
  • Huang L, Wang CF, Serhan CN, Strichartz G (2011). Enduring prevention and transient reduction of postoperative pain by intrathecal resolvin D1. Pain 152: 557565.
  • Kawasaki Y, Zhang L, Cheng JK, Ji RR (2008). Cytokine mechanisms of central sensitization: distinct and overlapping role of interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha in regulating synaptic and neuronal activity in the superficial spinal cord. J Neurosci 28: 51895194.
  • Krishnamoorthy S, Recchiuti A, Chiang N, Yacoubian S, Lee CH, Yang R et al. (2010). Resolvin D1 binds human phagocytes with evidence for proresolving receptors. Proc Natl Acad Sci U S A 107: 16601665.
  • Lima-Garcia JF, Dutra RC, da Silva KABS, Motta EM, Campos MM, Calixto JB (2011). The precursor of resolvin D series and aspirin-triggered resolvin D1 display anti-hyperalgesic properties in adjuvant-induced arthritis in rats. Br J Pharmacol 164: 278293.
  • Samad TA, Moore KA, Sapirstein A, Billet S, Allchorne A, Poole S et al. (2001). Interleukin-1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature 410: 471475.
  • Serhan CN (2007). Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. Annu Rev Immunol 25: 101137.
  • Serhan CN, Hong S, Gronert K, Colgan SP, Devchand PR, Mirick G et al. (2002). Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J Exp Med 196: 10251037.
  • Serhan CN, Chiang N, Van Dyke TE (2008). Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 8: 349361.
  • Sommer C, Birklein F (2010). Fighting off pain with resolvins. Nat Med 16: 518520.
  • Xu ZZ, Zhang L, Liu T, Park JY, Berta T, Yang R et al. (2010). Resolvins RvE1 and RvD1 attenuate inflammatory pain via central and peripheral actions. Nat Med 16: 592597.